Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Apr 25, 2023

In this interview, Dennis Bruemmer MD, PhD and Alison L. Bailey MD FACC, discuss Optimizing the Care of ASCVD Patients with T2DM. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe...


Apr 18, 2023

In this interview, David J. Maron MD, FACC and Richard A. Chazal MD, MACC, discuss Revascularization of Stable Ischemic Heart Disease in the Era of COURAGE, ISCHEMIA, and ORBITA. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to...


Apr 13, 2023

What are the practical considerations when determining the duration of antiplatelet regimens following PCI? 

In this interview, Mirvat Alasnag, FACP, FACC, FSCAI, FSCCT, and Sun Moon Kim, MD, FSCAI, FACC, discuss Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI? 

Subscribe on...


Apr 11, 2023

In this interview, Harriette GC Van Spall MD, MPH, FRCPC, and Clyde W. Yancy MD, MSc, MACC, FAHA, MACP, FHFSA, FASPC (Hon.), discuss the Basics of HF-rEF and Work Up. 

  Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to...


Apr 4, 2023

In this interim report of extended follow-up of ISCHEMIA, with a total of 557 deaths (nearly twice the number of deaths in the initial phase), the probability of a survival benefit at 7 years with either initial management strategy was not different. These findings provide important evidence for patients with chronic...